Estrasorb - Women's Health Resources

Site Map • Important Safety Info • Patient Info • Prescribing Info Healthcare Professionals

	Change Type Size: A A A

We want you to have all the information you need to make decisions about your healthcare. It’s important to talk with your healthcare professional about any questions or concerns you have.

You may also want to explore some of these Web sites:

Professional Organizations and Associations

http://www.menopause.org/
The North American Menopause Society (NAMS)

http://www.americanmenopause.org/
American Menopause Foundation

www.healthywomen.org
The National Women’s Health Resource Center

www.nwhn.org
National Women's Health Network

www.amwa-doc.org
American Medical Women's Association (AMWA)

www.npwh.org
National Association of Nurse Practitioners of Women’s Health (NPWH)

www.acog.com
Information from the American College of Obstetricians and Gynecologists

Government

www.fda.gov/womens/menopause
Menopause resources in English and Spanish from the FDA

www.fda.gov/cder/drug/infopage/estrogens_progestins
Hormone therapy materials from the FDA

www.nlm.nih.gov/medlineplus/menopause.html
Resources from the National Library of Medicine

www.nih.gov/PHTindex.htm
Menopausal Hormone Therapy Information from the National Institutes of Health (NIH)

Talk to your healthcare provider about Estrasorb for the relief of hot flashes and night sweats. If you and your healthcare provider decide Estrasorb is right for you, save $10 on your prescription!

About Esprit Pharma • Contact Us • Women's Health Resources

Important Safety Information
Estrasorb is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause. Estrasorb should not be used in women with any of the following conditions: undiagnosed abnormal genital bleeding; known, suspected, or history of cancer of the breast; known or suspected estrogen-dependent neoplasia; active deep-vein thrombosis, pulmonary embolism or history of these conditions; active or recent (eg, within the past year) arterial thromboembolic disease (eg, stroke, myocardial infarction); liver dysfunction or disease. Estrasorb should not be used in patients with known hypersensitivity to its ingredients; known or suspected pregnancy. There is no indication for Estrasorb in pregnancy. There appears to be little or no increased risk of birth defects in women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy (See PRECAUTIONS in full Prescribing Information).

The most frequently reported adverse events (≥5% and more frequently than placebo) in clinical trials for Estrasorb were: Infection; Sinusitis; Pruritus; Breast pain; and Endometrial disorder.

Important safety information you should know about estrogen.
Estrogens increase the chances of getting cancer of the uterus. Report any unusual vaginal bleeding right away while you are using Estrasorb. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare professional should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia.
Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with or without progestins may increase your risk of dementia, based on a study of women aged 65 years or older. You and your healthcare professional should talk regularly about whether you still need treatment with Estrasorb.

Please see Full Prescribing Information for Estrasorb.

For medical questions and to report adverse events, please call 1-866-230-0375.

If you are receiving communications from Esprit Pharma and would like to opt out, please click here .

ESTRASORB.com was last modified on: [MM/DD/YYYY Time am/pm]

Copyright © 2007 Esprit Pharma. Estrasorb is a registered trademark of Novavax, Inc.